`
`Import Alert 66-60
`
`1
`
`• •
`
`2
`•
`FDA Home3Import Program4Import AlertsImports Alerts by NumberImport Alert
`
`(Note: This import alert represents the Agency's current guidance to FDA field personnel regarding the manufacturer
`(s) and/or products(s) at issue. It does not create or confer any rights for or on any person, and does not operate to
`bind FDA or the public).
`
`Import Alert # 66-60
`Published Date: 03/18/2011
`Type: DWPE
`Import Alert Name:
`"Detention Without Physical Eamaintion of Certain Steroid Alternatives"
`
`Reason for Alert:
`Unapproved alternatives to anabolic steroids have commonly been found to present serious safety and effectiveness concerns. In
`February, 1991, anabolic steroids became controlled substances. This is one factor which has stimulated the market for imported
`steroid alternatives.
`
`Guidance:
`Districts may detain without physical examination all shipments of finished dosage forms (both commercial and personal) of the
`cited unapproved products. Do not collect samples for laboratory analysis. Districts should determine whether the drugs are
`covered by a current approved NDA or IND. Those products covered by an approved NDA or IND should be released.
`
`Bulk forms of these drugs may be detained under certain circumstances as misbranded drugs; however, prior to initiating any
`action against bulk pharmaceutical chemicals, contact CDER's Import/Export Branch.
`
`Product Description:
`Foreign manufactured unapproved drugs promoted as alternatives to certain anabolic steroids i.e.,
`
`* Yohimbe Bark or Yohimbe Bark Extract
`
`* Cyclofenil
`
`* Gamma Hydroxybutyrate (GHB)
`
`* Diosgenin
`
`* Clenbuterol
`
`Charge:
`"The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the
`meaning of Section 201(p) without an approved new drug application [Unapproved New Drug, Section 505(a)]."
`
`OASIS Charge Code - UNAPPROVED
`
`Countries
`MULTIPLE COUNTRIES (PODS ONLY)
`(60 D - - 99) Adrenocortical Steroid N.E.C.
`Notes:Yohimbe Bark or Yohimbe Bark Extract Cyclofenil Gamma Hydroxybutyrate (GHB) Diosgenin Clenbuterol
`
`Links on this page:
`
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`2. http://www.addthis.com/bookmark.php
`
`3. http://www.fda.gov/default.htm
`
`http://www.accessdata.fda.gov/cms_ia/importalert_198.html
`
`Page 1 of 2
`
` JAZZ EXHIBIT 2002
`Roxane Laboratories, Inc. et al. (Petitioners) v. Jazz Pharms., Inc. (Patent Owner)
` Case CBM2014-00175
`
`
`
`4. http://www.fda.gov/ForIndustry/ImportProgram/default.htm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`
`• Accessibility
`
`• Contact FDA
`
`• Careers
`
`• FDA Basics
`
`• FOIA
`
`• No Fear Act
`
`• Site Map
`
`• Transparency
`
`• Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Email FDA
`
`For Government
`
`• • • • • • • •
`
`• For Press
`
`• Combination Products
`
`• Advisory Committees
`
`• Science & Research
`
`• Regulatory Information
`
`• Safety
`
`• Emergency Preparedness
`
`• International Programs
`
`• News & Events
`
`• Training and Continuing Education
`
`• Inspections/Compliance
`
`• State & Local Officials
`
`• Consumers
`
`• Industry
`
`• Health Professionals
`
`Links on this page:
`
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`2. http://www.addthis.com/bookmark.php
`
`3. http://www.fda.gov/default.htm
`
`4. http://www.fda.gov/ForIndustry/ImportProgram/default.htm
`
`http://www.accessdata.fda.gov/cms_ia/importalert_198.html
`
`Page 2 of 2
`
`